Stryker

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. 

CEO
Kevin A. Lobo
CEOKevin A. Lobo
Employees
56,000
Employees56,000
Headquarters
Portage, Michigan
HeadquartersPortage, Michigan
Founded
1941
Founded1941
Employees
56,000
Employees56,000

SYK Key Statistics

Market cap
129.81B
Market cap129.81B
Price-Earnings ratio
40.38
Price-Earnings ratio40.38
Dividend yield
1.01%
Dividend yield1.01%
Average volume
1.71M
Average volume1.71M
High today
High today
Low today
Low today
Open price
$342.89
Open price$342.89
Volume
242.00
Volume242.00
52 Week high
$404.87
52 Week high$404.87
52 Week low
$319.32
52 Week low$319.32

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $337.99. The company's market cap stands at 129.81B, with a P/E ratio of 40.38 and a dividend yield of 1.0%.

On 2026-04-13, Stryker(SYK) shares started trading at $342.89, with intraday highs of — and lows of —.

Trading activity shows a volume of 242, compared to an average daily volume of 1.71M.

The stock's 52-week range extends from a low of $319.32 to a high of $404.87.

The stock's 52-week range extends from a low of $319.32 to a high of $404.87.

SYK News

TipRanks 16m
Stryker price target lowered to $397 from $412 at BTIG

BTIG lowered the firm’s price target on Stryker (SYK) to $397 from $412 and keeps a Buy rating on the shares as part of a broader research name on Medical Techn...

TipRanks 2h
Stryker initiated with an Outperform at Leerink

Leerink analyst Mike Kratky initiated coverage of Stryker (SYK) with an Outperform rating and $410 price target The firm says Stryker offers a compelling combin...

Simply Wall St 2d
How Stryker’s Restored Systems and Reaffirmed 2026 Outlook After Cyberattack Will Impact Stryker Investors

Stryker recently reported that its global manufacturing, ordering, and distribution systems are fully operational again after a March cyberattack that had mater...

How Stryker’s Restored Systems and Reaffirmed 2026 Outlook After Cyberattack Will Impact Stryker Investors

Analyst ratings

81%

of 31 ratings
Buy
80.6%
Hold
19.4%
Sell
0%

More SYK News

Simply Wall St 5d
If You Believe In Transformative AI Healthcare Stocks Then This Trio Resets Your Horizon Trajectory

Artificial intelligence in healthcare is one of the clearest ways technology meets real world need, especially as higher energy prices, geopolitical tension, an...

If You Believe In Transformative AI Healthcare Stocks Then This Trio Resets Your Horizon Trajectory
Simply Wall St 6d
If You Believe In AI Healthcare Then These Three Stocks Could Shape Your Next Cycle

AI is starting to reshape how healthcare is delivered, from spotting disease earlier to tailoring treatments and cutting wasted time in hospitals, just as energ...

If You Believe In AI Healthcare Then These Three Stocks Could Shape Your Next Cycle

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.